1352132-86-5Relevant articles and documents
PAK INHIBITORS FOR THE TREATMENT OF CANCER
-
, (2013/06/27)
Provided herein are methods of utilizing PAK inhibitors for the treatment of cancer. Further provided herein are compounds and formulations utilized for the treatment of cancer.
6-(ETHYNYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
-
, (2012/01/05)
Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders.